Life science campuses of yesteryear' tended to be remote, all-work-no-play settings Today's versions are city-centered and ...

Life sciences practice leaders expect an uptick in M&A work under the new Trump administration, while litigators in the industry expect work to remain relatively steady. As is the case in other ...

The life sciences industry is poised for an upswing in initial public offering (IPO) activity in 2026, supported by a large IPO backlog, the strong performance of biotech market indices, and positive ...

Over the past four years, private equity (PE) firms that invested in life science assets have faced a difficult reality. While many investors still debate whether some sectors of the market are in a ...